MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202641049658 A) filed by Anurag University, Hyderabad, Telangana, on April 18, for 'a standardized phytopharmaceutical composition of prunus avium (l.) for neuroprotection against cerebral ischemia-reperfusion injury.'
Inventor(s) include J. C. Hanish Singh; Dr. Krishna Prasad Devarakonda; Sayeda Jabeen; and Ms. Arpitaa Injamuri.
The application for the patent was published on May 1, under issue no. 18/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a standardized phyto pharmaceutical system (100) for neuroprotection against cerebral ischemia-reperfusion injury. The system comprises an experimental preparation unit (102) for selection and acclimatization of experimental subjects, a grouping unit (104) for random allocation into control and treatment groups, and a toxicity evaluation unit (106) for determining safe dosage through acute toxicity studies. An ischemia induction unit (108) is configured to induce cerebral ischemia using a middle cerebral artery occlusion (MCAO) model. An administration unit (110) delivers the standardized phyto pharmaceutical composition, while a behavioral assessment unit (112) evaluates neurological, motor, and cognitive functions. A biochemical analysis unit (114) estimates oxidative stress and antioxidant biomarkers including malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx). An outcome evaluation unit (116) determines neuroprotective efficacy based on behavioral and biochemical parameters. The system collectively enables assessment of neuroprotection by reducing oxidative stress, improving cognitive function, and restoring antioxidant defense mechanisms in ischemia-reperfusion conditions."
Disclaimer: Curated by HT Syndication.
